Lloyd Price

APRIL 27, 2024

Exec Summary: Generative AI is a powerful new tool with the potential to revolutionize healthcare. It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? Visit www.nelsonadvisors.co.uk

healthcare technology 73

healthcare technology Leadership Drug Development Digital Health 73

Lloyd Price

MAY 2, 2024

Digital Biology: Tools like BioNeMo utilise AI to analyse vast amounts of biological data, leading to breakthroughs in drug development and understanding of diseases. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Visit www.nelsonadvisors.co.uk

healthcare technology 73

healthcare technology Drug Development Leadership Digital Health 73

Lloyd Price

APRIL 22, 2024

Here are some of the ways that machine learning and computational algorithms are being used to aid diagnostics: Image analysis: Machine learning algorithms can be trained to identify abnormalities in medical images, such as X-rays, mammograms, and CT scans. Visit www.nelsonadvisors.co.uk Subscribe Today! Subscribe Today! Subscribe Today!

healthcare technology 60

healthcare technology Leadership Drug Development Digital Health 60

Lloyd Price

FEBRUARY 22, 2024

Overall, the pain management market is poised for significant growth, fuelled by technological innovation and a growing demand for effective, non-opioid solutions. Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.

Pain management 56

Pain management Mental health Telehealth healthcare technology 56

Healthcare IT News - Telehealth

MAY 6, 2020

CAREMINDr is a health IT communications company that provides mobile-enabled remote patient monitoring systems that give physicians the ability to enroll their patients in condition-specific “journeys,” such as for diabetes and hypertension. iRhythm Technologies.

Connected Health 183

Connected Health Telehealth Pharmaceuticals EHR 183

Healthcare IT Today

APRIL 25, 2024

This contextual understanding is pivotal in drug development decision-making, revealing patient selection insights unpredictable using today’s tools to maximize the value of both approved medicines and drugs in development.” Cooley LLP served as legal counsel for Zephyr AI.

Drug Development 99

Drug Development healthcare technology Health IT Healthcare IT 99